Literature DB >> 11140365

Cardiovascular responses of the taurine-depleted rat to vasoactive agents.

M S Mozaffari1, W Abebe.   

Abstract

The objective of this study was to assess the effect of taurine-depletion on cardiovascular responses of rat to vasoactive agents. Male Wistar-Kyoto (WKY) rats were given either tap water (control) or 3% beta-alanine (taurine-depleted) for three weeks. Thereafter, mean arterial pressure (MAP) and heart rate of the freely moving animal were measured in response to vasoactive agents. Administration of phenylephine (5-40 microg/kg/min; i.v.) resulted in a similar and significant increase in MAP but a reduction in heart rate in both control and taurine-depleted groups. On the other hand, administration of sodium nitroprusside (15-300 microg/kg/min; i.v.) elicited a similar and significant reduction in MAP but increased heart rate in both groups. Lack of a differential response to phenylephrine and sodium nitroprusside between the two groups suggests that baroreflex regulation of cardiovascular function is not adversely affected by taurine-depletion. Administration of angiotensin II (0.1-3.0 microg/kg/min; i.v.) resulted in a dose-related increase in the pressor response and a decrease in heart rate in both groups. However, angiotensin II-induced pressor response was reduced in the taurine-depleted compared to the control rats (p < 0.05); heart rate was similarly reduced in both groups. Acute exposure to beta-alanine (3 g/kg; i.v., 30-minutes) did not alter angiotensin II-induced hemodynamic responses. Similarly, incubation of aortic rings with beta-alanine (40mM, 30 minutes) did not affect the contractile responses to angiotensin II. The results suggest that beta-alanine, per se, does not affect angiotensin II-induced responses in rat. However, beta-alanine-induced taurine depletion is associated with a reduction in the pressor response to angiotensin II without impairing baroreflex function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140365     DOI: 10.1007/s007260070012

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  5 in total

1.  Role of taurine in the vasculature: an overview of experimental and human studies.

Authors:  Worku Abebe; Mahmood S Mozaffari
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 2.  Effects of taurine on vascular tone.

Authors:  Oguzhan Yildiz; Kemal Gokhan Ulusoy
Journal:  Amino Acids       Date:  2022-08-19       Impact factor: 3.789

Review 3.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

4.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

5.  Atrophic cardiac remodeling induced by taurine deficiency in Wistar rats.

Authors:  Mariele Castilho Pansani; Paula S Azevedo; Bruna Paola Murino Rafacho; Marcos F Minicucci; Fernanda Chiuso-Minicucci; Sofia Gonçalves Zorzella-Pezavento; Julio Sergio Marchini; Gilberto João Padovan; Ana Angelica Henrique Fernandes; Beatriz B Matsubara; Luiz S Matsubara; Leonardo A M Zornoff; Sergio A R Paiva
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.